Defence scientists have developed a drug from medicinal plants that is proving to be effective for leucoderma (white patches on skin), considered an incurable disease.
The herbal drug, Lukoskin, has been developed by the scientists of the Defence Bio-Energy Research (DIBER), Haldwani (Uttarakhand), a laboratory of the Defence Research and Development Organisation (DRDO).
DIBER has transferred the technology of the drug, which is being showcased at the ongoing Arogya Expo 2014 alongside the sixth World ayurveda Congress, to AIMIL Pharmaceuticals India Ltd for its commercial production and sale.
Dr. Mohammad Junail of AIMIL said his company has signed an agreement with DRDO for the commercial launch of three of their herbal products.
"Lukosin has already been launched. The two other products will soon be commercially launched in Indian markets," he informed.
Leucoderma is generally considered an incurable disease, but Lukosin has been extremely effective against it. The drug is also on sale at the expo.
"The quest to cure leucoderma (Vitiligo) has finally ended with the development of the new herbal product with extensive studies by the scientists of DIBER. It can effectively combat the ailment and render the much-needed service to mankind," said Dr. W. Selvamurthy of DRDO.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
